The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway.
The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway.
复制标题
DOI:
10.3389/fimmu.2012.00190
复制
发表时间:
2012
影响因子:
7.3
通讯作者:
Sitkovsky M
中科院分区:
文献类型:
--
作者:
Ohta A;Kini R;Ohta A;Subramanian M;Madasu M;Sitkovsky M
The A2A adenosine receptor (A2AR)-mediated immunosuppression is firmly implicated in the life-saving down-regulation of collateral tissue damage during the anti-pathogen immune response and in highly undesirable protection of cancerous tissues during anti-tumor immune response. Therefore, depending on specific clinical situation there is a need to either weaken or strengthen the intensity of A2AR signal. While the A2AR-mediated immunosuppression was shown to be T cell autonomous in studies of effector T cells, it was not clear how A2AR stimulation affects regulatory T cells (Treg). Here we show in parallel assays that while A2AR stimulation on T cells directly inhibits their activation, there is also indirect and longer-lasting T cell inhibitory effect through modulation of Treg. A2AR stimulation expanded CD4+ CD25hi FoxP3+ cells, which also express CD39, CD73, and CTLA-4. Treg cultured with A2AR agonist showed increased expression of CTLA-4 and stronger immunosuppressive activity. There was a significant increase of Treg cell number after A2AR stimulation. The CD4+ FoxP3+ population contained those induced from CD4+ CD25− cells, but CD4+ FoxP3+ cells predominantly derived from CD4+ CD25+ natural Treg. Thus, A2AR stimulation numerically and functionally enhanced Treg-mediated immunosuppressive mechanism. These data suggest that the A2AR-mediated stimulation of lymphocytes using A2AR agonists should be considered in protocols for ex vivo expansion of Treg before the transfer to patients in different medical applications.
登录
查看更多内容
DOI:
10.1084/jem.161.1.72
发表时间:
1985-01-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Sakaguchi S;Fukuma K;Kuribayashi K;Masuda T
通讯作者:
Masuda T
影响因子:
5.4
作者:
Hoffmann, Petra;Boeld, Tina J.;Edinger, Matthias
通讯作者:
Edinger, Matthias
影响因子:
4.4
作者:
Pouliot, M;Fiset, MÉ;Borgeat, P
通讯作者:
Borgeat, P
影响因子:
4
作者:
Cadieux, JS;Leclerc, P;Pouliot, M
通讯作者:
Pouliot, M
DOI:
10.1073/pnas.0605251103
发表时间:
2006-08-29
影响因子:
11.1
作者:
Ohta, Akio;Gorelik, Elieser;Sitkovsky, Michail
通讯作者:
Sitkovsky, Michail